chartexchange

RGBP
REGEN BIOPHARMA INC
stockOTC

EODNov 17, 2026
0.0001USD-42.857%(-0.0001)2,924,866
Loading…
Loading…
Healthcare
Biotechnology
HQ
La Mesa, CA, USA
Previous Close
$0.00
Beta
-106.81
52-Week High
$0.01 2025-12-05
52-Week Low
$0.00 2026-11-12
SMA 50
$0.00
SMA 200
$0.00
Avg. Vol 10D
8.55M
Avg. Vol 30D
5.26M
Avg. Vol 90D
15.25M
Relative Vol
0.56
1.62B
2,531,995
Jul 5, 2024 · 3-for-1
RGBP Profile

regen biopharma, inc. focuses on the development of small molecule therapies for treating cancer and autoimmune disorders in the united states. the company intends to develop small molecule nr2f6 that activates to immune cell for oncology and autoimmune diseases. the company was founded in 2012 and is based in la mesa, california. regen biopharma, inc. is a subsidiary of bio-matrix scientific group, inc.

RGBP Performance
PeriodPriceDateChangeBeta
1M0.002026-10-19-33.33%-419.614
6M0.002026-05-18-75.00%-162.814
1Y0.012025-11-18-98.96%-106.813
2Y0.082024-11-18-99.87%—
5Y10.502021-11-18-100.00%-13.554
RGBP Stock Summary

REGEN BIOPHARMA INC (OTC:RGBP) stock price today is $0.00, and today's volume is 2,924,866. RGBP is down 42.857% today. The 30 day average volume is 5.26M. RGBP market cap is $451 with 4.51M shares outstanding.